FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.9.1  |  FHIR Version n/a  User: [n/a]

519311000001107: Femoston-conti 1mg/5mg tablets (Viatris UK Healthcare Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2119861000001111 Femoston-conti 1mg/5mg tablets (Viatris UK Healthcare Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2119871000001118 Femoston-conti 1mg/5mg tablets (Viatris UK Healthcare Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
17085501000001119 Femoston-conti tablets (Solvay Healthcare Ltd) (product) en Fully specified name Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module
17085601000001115 Femoston-conti tablets (Solvay Healthcare Ltd) en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module
37787101000001115 Femoston-conti 1mg/5mg tablets (Solvay Healthcare Ltd) en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
63680301000001113 Femoston-conti 1mg/5mg tablets (Abbott Healthcare Products Ltd) en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module
90063001000001112 Femoston-conti 1mg/5mg tablets (BGP Products Ltd) en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module
102356701000001116 Femoston-conti 1mg/5mg tablets (Mylan Ltd) en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module
105697001000001119 Femoston-conti 1mg/5mg tablets (Mylan) en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Femoston-conti 1mg/5mg tablets (Viatris UK Healthcare Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Femoston-conti 1mg/5mg tablets (Viatris UK Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Femoston-conti 1mg/5mg tablets (Viatris UK Healthcare Ltd) Is a Dydrogesterone 5mg / Estradiol 1mg tablets true Inferred relationship Existential restriction modifier
Femoston-conti 1mg/5mg tablets (Viatris UK Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Femoston-conti 1mg/5mg tablets (Viatris UK Healthcare Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Femoston-conti 1mg/5mg tablets (Viatris UK Healthcare Ltd) Has active ingredient Dydrogesterone true Inferred relationship Existential restriction modifier
Femoston-conti 1mg/5mg tablets (Viatris UK Healthcare Ltd) Has active ingredient Estradiol true Inferred relationship Existential restriction modifier
Femoston-conti 1mg/5mg tablets (Viatris UK Healthcare Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Femoston-conti 1mg/5mg tablets (Viatris UK Healthcare Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Femoston-conti 1mg/5mg tablets (Viatris UK Healthcare Ltd) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Femoston-conti 1mg/5mg tablets (Viatris UK Healthcare Ltd) Is a Femoston-conti true Inferred relationship Existential restriction modifier
Femoston-conti 1mg/5mg tablets (Viatris UK Healthcare Ltd) Has specific active ingredient Estradiol true Inferred relationship Existential restriction modifier
Femoston-conti 1mg/5mg tablets (Viatris UK Healthcare Ltd) Has specific active ingredient Dydrogesterone true Inferred relationship Existential restriction modifier
Femoston-conti 1mg/5mg tablets (Viatris UK Healthcare Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Femoston-conti 1mg/5mg tablets (Viatris UK Healthcare Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Femoston-conti 1mg/5mg tablets (Viatris UK Healthcare Ltd) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Femoston-conti 1mg/5mg tablets (Viatris UK Healthcare Ltd) 84 tablet 3 x 28 tablets Is pack of False Femoston-conti 1mg/5mg tablets (Viatris UK Healthcare Ltd) Inferred relationship Existential restriction modifier
Femoston-conti 1mg/5mg tablets (Viatris UK Healthcare Ltd) 84 tablet 3 x 28 tablets Has AMP True Femoston-conti 1mg/5mg tablets (Viatris UK Healthcare Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start